Insulin Sensitizers for Polycystic Ovary Syndrome

This publication has 40 references indexed in Scilit:

• Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
  New England Journal of Medicine, 2002
• Myocardial infarction in users of low-dose oral contraceptives
  Published by Wolters Kluwer Health ,1999
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
  The Lancet, 1998
• Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome
  Fertility and Sterility, 1998
• Menstrual Cyclicity After Metformin Therapy in Polycystic Ovary Syndrome
  Obstetrics & Gynecology, 1997
• A Prospective Study of Oral Contraceptives and NIDDM Among U.S. Women
  Diabetes Care, 1997
• Decreases in Ovarian Cytochrome P450c17α Activity and Serum Free Testosterone after Reduction of Insulin Secretion in Polycystic Ovary Syndrome
  New England Journal of Medicine, 1996
• Stroke in Users of Low-Dose Oral Contraceptives
  New England Journal of Medicine, 1996
• Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy
  Metabolism, 1994
• Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome
  Diabetes, 1989